Literature DB >> 21821340

[Rationale and methods of the study on nutrition and cardiovascular risk in Spain (ENRICA)].

Fernando Rodríguez-Artalejo1, Auxiliadora Graciani, Pilar Guallar-Castillón, Luz M León-Muñoz, M Clemencia Zuluaga, Esther López-García, Juan Luis Gutiérrez-Fisac, José M Taboada, M Teresa Aguilera, Enrique Regidor, Fernando Villar-Álvarez, José R Banegas.   

Abstract

INTRODUCTION AND
OBJECTIVES: The ENRICA study aims to assess the frequency and distribution of the main components of the natural history of cardiovascular disease in Spain, including food consumption and other behavioral risk factors, biological risk factors, early damage of target organs, and diagnosed morbidity.
METHODS: A cross-sectional survey of 11,991 individuals representative of the non-institutionalized population aged 18 years and older in Spain was conducted from June 2008 to October 2010. Data collection comprised 3 sequential stages: a) computer-assisted telephone interview to obtain information on lifestyle, knowledge and attitudes about cardiovascular disease risk factors, and the signs and symptoms of heart attack and stroke, subjective health, and morbidity; b) first home visit, to collect blood and urine samples for analysis by a central laboratory, and c) second home visit, to measure anthropometric variables and blood pressure and to administer a computer-assisted dietary history; data on functional limitations are also collected from participants aged 65 years and older. DISCUSSION: The ENRICA study has shown the feasibility of a large home-based health interview and examination survey in Spain. It will provide valuable information to support and evaluate national strategies against cardiovascular disease and other chronic diseases in Spain. Moreover, a 3-year prospective follow-up of the study participants, including a new physical exam, is planned to start in the second semester of 2011 and will update lifestyle information and biological variables. (ClinicalTrials.gov number, NCT01133093).
Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21821340     DOI: 10.1016/j.recesp.2011.05.019

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  44 in total

1.  Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; Esther López-García; Pilar Guallar-Castillón; Esther García-Esquinas; Fernando Rodríguez-Artalejo; José R Banegas
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

2.  Consumption of soft drinks and health-related quality of life in the adult population.

Authors:  A Lana; E Lopez-Garcia; F Rodríguez-Artalejo
Journal:  Eur J Clin Nutr       Date:  2015-07-01       Impact factor: 4.016

3.  Only virgin type of olive oil consumption reduces the risk of mortality. Results from a Mediterranean population-based cohort.

Authors:  Carolina Donat-Vargas; Esther Lopez-Garcia; José R Banegas; Miguel Á Martínez-González; Fernando Rodríguez-Artalejo; Pilar Guallar-Castillón
Journal:  Eur J Clin Nutr       Date:  2022-10-14       Impact factor: 4.884

4.  Patterns of alcohol consumption and risk of falls in older adults: a prospective cohort study.

Authors:  R Ortolá; E García-Esquinas; I Galán; P Guallar-Castillón; E López-García; J R Banegas; F Rodríguez-Artalejo
Journal:  Osteoporos Int       Date:  2017-07-19       Impact factor: 4.507

5.  Association between telomere length, frailty and death in older adults.

Authors:  Fernando Rodríguez-Artalejo; Leocadio Rodríguez-Mañas; Mariam El Assar; Javier Angulo; José A Carnicero; Stefan Walter; Francisco J García-García
Journal:  Geroscience       Date:  2020-11-15       Impact factor: 7.713

6.  Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in Spain.

Authors:  José R Banegas; Juan J de la Cruz; Auxiliadora Graciani; Esther López-García; Teresa Gijón-Conde; Luis M Ruilope; Fernando Rodriguez-Artalejo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-16       Impact factor: 3.738

7.  Metabolic syndrome and Growth Differentiation Factor 15 in older adults.

Authors:  Adrián Carballo-Casla; Esther García-Esquinas; Antonio Buño-Soto; Ellen A Struijk; Esther López-García; Fernando Rodríguez-Artalejo; Rosario Ortolá
Journal:  Geroscience       Date:  2021-05-07       Impact factor: 7.581

8.  Development of a common scale for measuring healthy ageing across the world: results from the ATHLOS consortium.

Authors:  Albert Sanchez-Niubo; Carlos G Forero; Yu-Tzu Wu; Iago Giné-Vázquez; Matthew Prina; Javier De La Fuente; Christina Daskalopoulou; Elena Critselis; Alejandro De La Torre-Luque; Demosthenes Panagiotakos; Holger Arndt; José Luis Ayuso-Mateos; Ivet Bayes-Marin; Jerome Bickenbach; Martin Bobak; Francisco Félix Caballero; Somnath Chatterji; Laia Egea-Cortés; Esther García-Esquinas; Matilde Leonardi; Seppo Koskinen; Ilona Koupil; Blanca Mellor-Marsá; Beatriz Olaya; Andrzej Pająk; Martin Prince; Alberto Raggi; Fernando Rodríguez-Artalejo; Warren Sanderson; Sergei Scherbov; Abdonas Tamosiunas; Beata Tobias-Adamczyk; Stefanos Tyrovolas; Josep Maria Haro
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

9.  The diet of diabetic patients in Spain in 2008-2010: accordance with the main dietary recommendations--a cross-sectional study.

Authors:  Maritza Muñoz-Pareja; Luz M León-Muñoz; Pilar Guallar-Castillón; Auxiliadora Graciani; Esther López-García; José R Banegas; Fernando Rodríguez-Artalejo
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

10.  Achievement of cardiometabolic goals among diabetic patients in Spain. A nationwide population-based study.

Authors:  Beatriz Navarro-Vidal; José R Banegas; Luz M León-Muñoz; Fernando Rodríguez-Artalejo; Auxiliadora Graciani
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.